Furthermore, some newer biomarkers such as Lungen-6 (KL-6), surfactant protein-D (SP-D), and CCL18 are limited to the detection of complications such as interstitial lung disease (ILD)11. The gene discussed is SFTPD; the disease is interstitial lung disease.